200 related articles for article (PubMed ID: 6098935)
1. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
Jarzabek Z; Kańtoch M
Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
[No Abstract] [Full Text] [Related]
2. Prevalence of poliovirus neutralizing antibodies. A seroepidemiologic survey of vaccinated and unvaccinated women of fertile age.
Moschen ME; Farisano G; Bonello C; Benussi G; Barbone F; Gasparini V; Trivello R
Boll Ist Sieroter Milan; 1987; 66(2):97-100. PubMed ID: 2822063
[TBL] [Abstract][Full Text] [Related]
3. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
Yang C; Shi H; Zhou J; Liang Y; Xu H
Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
[TBL] [Abstract][Full Text] [Related]
4. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
Kuwert E; Höher PG; Thraenhart O
Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
[TBL] [Abstract][Full Text] [Related]
5. [Poliomyelitis immunity status in the centro-meridional Italy].
Ribera G; Angelillo IF; Ricciardi G; Grasso GM; Villari P
Ann Ig; 1995; 7(6):421-9. PubMed ID: 8663971
[No Abstract] [Full Text] [Related]
6. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1987 Dec; 36(48):795-8. PubMed ID: 3119980
[No Abstract] [Full Text] [Related]
7. [Antigenicity determination of inactivated poliovirus--the micro-neutralization inhibition test].
Jiang SD; Pye D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Aug; 7(4):309-12. PubMed ID: 3011295
[No Abstract] [Full Text] [Related]
8. Poliomyelitis immunity status in Italian and foreign subjects.
Tanzi ML; Bracchi U; Affanni P; Dall'Argine A; Bombarda G; Bellelli E
Ann Ig; 1992; 4(4):191-7. PubMed ID: 1284576
[No Abstract] [Full Text] [Related]
9. Persistence of poliovirus neutralizing antibodies eight years after immunization with live, attenuated-virus vaccine.
Rousseau WE; Noble GR; Tegtmeier GE; Jordan MC; Chin TD
N Engl J Med; 1973 Dec; 289(25):1357-9. PubMed ID: 4356637
[No Abstract] [Full Text] [Related]
10. [Studies on new attenuated strains of type I live poliovirus vaccine. II. Investigation on a series of field trials with "Zhong I9" strain].
Chen TQ; Li CZ; Ni SF; Shi M; Luo GX; Dong DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):373-7. PubMed ID: 6327097
[No Abstract] [Full Text] [Related]
11. [Stage of immunity to Poliovirus type 1 and 3 in adult women and in newborn infants: study of comparative efficiency of 2 methods for determination of neutralizing antibodies].
Barbi M
Ann Sclavo; 1972; 14(6):694-704. PubMed ID: 4360238
[No Abstract] [Full Text] [Related]
12. Seroimmunity to poliovirus in Poitiers, France.
Agius G; Ranger S; Baillargeau E; Rouches C; Castets M
Eur J Clin Microbiol; 1986 Apr; 5(2):171-3. PubMed ID: 3013629
[No Abstract] [Full Text] [Related]
13. Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.
Herremans MM; Reimerink JH; Ras A; Van Der Avoort HG; Kimman TG; Van Loon AM; Conyn-Van Spaendonck MA; Koopmans MP
Clin Diagn Lab Immunol; 1997 Nov; 4(6):659-64. PubMed ID: 9384285
[TBL] [Abstract][Full Text] [Related]
14. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
[TBL] [Abstract][Full Text] [Related]
15. Inactivated poliovirus vaccine in Finland.
Oker-Blom N; Penttinen K; Weckström P
Rev Infect Dis; 1984; 6 Suppl 2():S461-2. PubMed ID: 6330842
[No Abstract] [Full Text] [Related]
16. Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine.
Dragunsky EM; Ivanov AP; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
J Infect Dis; 2006 Sep; 194(6):804-7. PubMed ID: 16941347
[TBL] [Abstract][Full Text] [Related]
17. [Antibody response in subjects vaccinated with a recall dose of the Sabin or Salk type vaccine].
Squeri L; Calisto ML; Sindoni L; Mattace-Raso G
Ann Sclavo; 1973; 15(6):569-80. PubMed ID: 4369487
[No Abstract] [Full Text] [Related]
18. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
[TBL] [Abstract][Full Text] [Related]
19. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic.
Schaap GJ; Bijkerk H; Coutinho RA; Kapsenberg JG; van Wezel AL
Prog Med Virol; 1984; 29():124-40. PubMed ID: 6322230
[No Abstract] [Full Text] [Related]
20. [Revaccination of school children with a live vaccine against poliomyelitis].
Koza J; Matyásová I; Skovránek V; Danes L; Losová M
Cesk Pediatr; 1983 Apr; 38(4):207-11. PubMed ID: 6303606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
